Sylvamo (SLVM)
(Real Time Quote from BATS)
$85.32 USD
+0.42 (0.50%)
Updated Sep 25, 2024 01:10 PM ET
1-Strong Buy of 5 1
B Value C Growth C Momentum B VGM
Income Statements
Fiscal Year end for Sylvamo Corporation falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 3,721 | 3,628 | 3,502 | 3,009 | 4,017 |
Cost Of Goods | 2,809 | 2,619 | 2,298 | 2,101 | 2,638 |
Gross Profit | 912 | 1,009 | 1,204 | 908 | 1,379 |
Selling & Adminstrative & Depr. & Amort Expenses | 486 | 450 | 719 | 684 | 847 |
Income After Depreciation & Amortization | 426 | 559 | 485 | 224 | 532 |
Non-Operating Income | -57 | -92 | -25 | -26 | -30 |
Interest Expense | 0 | 0 | 0 | 0 | 0 |
Pretax Income | 369 | 467 | 460 | 198 | 502 |
Income Taxes | 116 | 131 | 129 | 28 | 125 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 253 | 336 | 331 | 170 | 377 |
Extras & Discontinued Operations | 0 | -218 | 0 | 0 | 0 |
Net Income (GAAP) | 253 | 118 | 331 | 170 | 377 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 569 | 684 | 628 | 378 | 724 |
Depreciation & Amortization (Cash Flow) | 143 | 125 | 143 | 154 | 192 |
Income After Depreciation & Amortization | 426 | 559 | 485 | 224 | 532 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 42.00 | 44.00 | 44.00 | NA | NA |
Diluted EPS Before Non-Recurring Items | 6.51 | 7.84 | 6.94 | NA | NA |
Diluted Net EPS (GAAP) | 5.93 | 2.66 | 7.53 | NA | NA |
Fiscal Year end for Sylvamo Corporation falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 933.00 | 905.00 | 946.00 | 897.00 | 919.00 |
Cost Of Goods | 684.00 | 716.00 | 735.00 | 665.00 | 721.00 |
Gross Profit | 249.00 | 189.00 | 211.00 | 232.00 | 198.00 |
SG&A, R&D, and Dept/Amort Expenses | 119.00 | 113.00 | 134.00 | 125.00 | 110.00 |
Income After SG&A, R&D, and Dept/Amort Expenses | 130.00 | 76.00 | 77.00 | 107.00 | 88.00 |
Non-Operating Income | -17.00 | -16.00 | -10.00 | -16.00 | -18.00 |
Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Pretax Income | 113.00 | 60.00 | 67.00 | 91.00 | 70.00 |
Income Taxes | 30.00 | 17.00 | 18.00 | 33.00 | 21.00 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | 83.00 | 43.00 | 49.00 | 58.00 | 49.00 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | 83.00 | 43.00 | 49.00 | 58.00 | 49.00 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 42.00 | 42.00 | 42.00 | 42.00 | 43.00 |
Diluted EPS Before Non-Recurring Items | 1.98 | 1.07 | 1.16 | 1.70 | 1.14 |
Diluted Net EPS (GAAP) | 1.98 | 1.02 | 1.17 | 1.37 | 1.14 |